No Data
Cantor Fitzgerald Initiates TriSalus Life Sciences(TLSI.US) With Buy Rating, Announces Target Price $10
Express News | Cantor Fitzgerald Initiates Coverage On TriSalus Life Sciences With Overweight Rating, Announces Price Target of $10
Insider Purchase: Director at $TLSI (TLSI) Buys 2,040 Shares
Maxim Group Maintains TriSalus Life Sciences(TLSI.US) With Buy Rating, Maintains Target Price $16
TriSalus Life Sciences: Strong Buy Recommendation Supported by Robust Financial Growth and Strategic Advancements
TriSalus Life Sciences Is Maintained at Buy by Canaccord Genuity
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
